Walgreen faces off with the DEA over painkiller distribution

03/20/2013 | Miami Herald (free registration), The

Walgreen is appealing an order by the DEA to suspend shipments of controlled substances, such as oxycodone, from its Jupiter, Fla., distribution center in a case before the U.S. Court of Appeals in Washington, D.C., on Thursday. The DEA claims that the center, one of Walgreen's 13 nationwide, has a history of filling suspicious drug orders and is a public safety threat. In a brief, Walgreen said, "This case involves an abuse of the extraordinary power that the Drug Enforcement Administration wields over ordinary citizens and businesses."

View Full Article in:

Miami Herald (free registration), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Chief Executive Officer
UCare Minnesota
Minneapolis, MN